2023 - Research.com Immunology in Israel Leader Award
2022 - Research.com Immunology in Israel Leader Award
His primary areas of investigation include Transplantation, Immunology, Internal medicine, Bone marrow and Stem cell. His Transplantation study combines topics in areas such as Virology, Immunosuppression, Immune tolerance, Immune system and Fludarabine. The study incorporates disciplines such as Graft-versus-host disease and Busulfan in addition to Immunology.
He combines subjects such as Gastroenterology, Transplantation Conditioning, Surgery and Oncology with his study of Internal medicine. He has included themes like Cell therapy, Leukemia, Acute lymphocytic leukemia and Immunotherapy in his Bone marrow study. His research in Stem cell intersects with topics in Cancer research and Mesenchymal stem cell.
His scientific interests lie mostly in Immunology, Transplantation, Bone marrow, Internal medicine and Stem cell. Within one scientific family, Shimon Slavin focuses on topics pertaining to Haematopoiesis under Immunology, and may sometimes address concerns connected to Progenitor cell and Stromal cell. He has researched Transplantation in several fields, including Regimen and Fludarabine.
The Bone marrow study combines topics in areas such as Spleen, Immunosuppression, Cytokine and T cell. His Internal medicine research includes elements of Gastroenterology, Endocrinology, Surgery and Oncology. The concepts of his Stem cell study are interwoven with issues in Cancer research and Mesenchymal stem cell.
Immunology, Transplantation, Internal medicine, Stem cell and Surgery are his primary areas of study. His research in Immunology intersects with topics in Haematopoiesis and Graft-versus-host disease. His Transplantation research integrates issues from Myeloid, Leukemia, Survival rate and Immunotherapy.
His Internal medicine research includes themes of Gastroenterology and Oncology. His Stem cell research is multidisciplinary, incorporating perspectives in Cancer research, T cell, Toxicity, Mesenchymal stem cell and Bone marrow. In his research on the topic of Hematopoietic stem cell transplantation, Survival analysis is strongly related with Transplantation Conditioning.
Shimon Slavin mainly focuses on Internal medicine, Stem cell, Transplantation, Immunology and Surgery. The various areas that he examines in his Internal medicine study include Gastroenterology, Transplantation Conditioning, Oncology and Endocrinology. Shimon Slavin has included themes like SOX2, Cancer research and Mesenchymal stem cell in his Stem cell study.
While the research belongs to areas of Transplantation, Shimon Slavin spends his time largely on the problem of Survival rate, intersecting his research to questions surrounding Cancer. His work carried out in the field of Immunology brings together such families of science as Adverse effect, Intention-to-treat analysis and Neuroprotection. The Surgery study combines topics in areas such as Paroxysmal nocturnal hemoglobinuria, Platelet, Peliosis hepatis and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
Shimon Slavin;Arnon Nagler;Ella Naparstek;Yossi Kapelushnik.
Defining the intensity of conditioning regimens: working definitions.
Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt.
Biology of Blood and Marrow Transplantation (2009)
Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning
Alessandro Aiuti;Shimon Slavin;Memet Aker;Francesca Ficara.
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff.
The New England Journal of Medicine (2009)
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
Dimitrios Karussis;Clementine Karageorgiou;Adi Vaknin-Dembinsky;Basan Gowda-Kurkalli.
JAMA Neurology (2010)
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
H. Waldmann;G. Hale;G. Cividalli;Z. Weshler.
The Lancet (1984)
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
Shimon Slavin;Elizabeth Naparstek;Arnon Nagler;Aliza Ackerstein.
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.
Shimon Slavin;Samuel Strober;Zvi Fuks;Henry S. Kaplan.
Journal of Experimental Medicine (1977)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza.
Lancet Oncology (2009)
Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella.
Journal of Clinical Oncology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: